Molnupiravir

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Molnupiravir[edit | edit source]

Molnupiravir chemical structure

Molnupiravir is an antiviral medication that is used to treat COVID-19. It was developed by the pharmaceutical companies Merck & Co. and Ridgeback Biotherapeutics. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action by introducing errors into the viral RNA during replication.

Mechanism of Action[edit | edit source]

Molnupiravir works by incorporating itself into the viral RNA. Once inside the viral RNA, it causes mutations during the replication process. These mutations accumulate and lead to "error catastrophe," which reduces the ability of the virus to replicate and spread.

Molnupiravir metabolism

The drug is metabolized into its active form, N4-hydroxycytidine, which is then phosphorylated to the active triphosphate form. This active form is incorporated into the viral RNA by the viral RNA-dependent RNA polymerase.

Chemical Properties[edit | edit source]

Molnupiravir is a prodrug, meaning it is metabolized in the body to become an active pharmacological agent. Its chemical structure allows it to mimic the natural nucleosides used by the virus to replicate its RNA.

Synthesis[edit | edit source]

Molnupiravir synthesis

The synthesis of molnupiravir involves several chemical reactions starting from uridine, a naturally occurring nucleoside. The process includes the introduction of a hydroxylamine group to form N4-hydroxycytidine, which is then converted into molnupiravir.

Bonding and Interaction with Viral RNA[edit | edit source]

Molnupiravir GC bonding

Molnupiravir can pair with both guanine and adenine, leading to G-to-A and C-to-U transitions in the viral genome. This dual pairing ability is crucial for its mechanism of inducing lethal mutagenesis in the virus.

Molnupiravir AU bonding

Clinical Use[edit | edit source]

Molnupiravir is administered orally and is used in the treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe disease. It is typically prescribed for patients who cannot receive other treatments or for whom other treatments are not appropriate.

Safety and Efficacy[edit | edit source]

Clinical trials have shown that molnupiravir can reduce the risk of hospitalization and death in patients with COVID-19. However, its use is subject to ongoing evaluation, and it is important to consider potential side effects and contraindications.

Related Pages[edit | edit source]

Drugs for HIV Infection, in the Subclass Antiretroviral Agents

Drugs for Hepatitis B

Drugs for Hepatitis C

HCV NS5A Inhibitors

HCV NS5B Inhibitors (Polymerase inhibitors)

HCV Protease Inhibitors

Combination Therapies

Drugs for Herpes Virus

Acyclovir, Cidofovir, Famciclovir, Foscarnet, Ganciclovir, Valacyclovir, Valganciclovir

Drugs for Influenza

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD